Published in Clin Rheumatol on February 09, 2014
NADPH oxidase-induced NALP3 inflammasome activation is driven by thioredoxin-interacting protein which contributes to podocyte injury in hyperglycemia. J Diabetes Res (2015) 1.43
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives. Mediators Inflamm (2015) 0.89
Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease. J Am Soc Nephrol (2016) 0.86
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. Front Pharmacol (2016) 0.84
Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases. Pediatr Nephrol (2015) 0.79
AAO: Autoimmune and Autoinflammatory (Disease) in Otology: What is New in Immune-Mediated Hearing Loss. Laryngoscope Investig Otolaryngol (2016) 0.78
Secondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damage. World J Nephrol (2016) 0.76
A case of cryopyrin-associated periodic syndrome with kidney transplant failure. CEN Case Rep (2014) 0.75
Oxalate, inflammasome, and progression of kidney disease. Curr Opin Nephrol Hypertens (2016) 0.75
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature. Clin Rheumatol (2017) 0.75
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art. Clin Rheumatol (2015) 0.75
Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet (2001) 9.34
Molecular mechanisms of amyloidosis. N Engl J Med (2003) 7.75
Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med (2009) 5.19
Natural history and outcome in systemic AA amyloidosis. N Engl J Med (2007) 4.54
Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet (2001) 2.71
Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum (2002) 2.58
Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int (2005) 2.43
In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes. J Exp Med (2009) 2.34
Updates in cardiac amyloidosis: a review. J Am Heart Assoc (2012) 2.21
The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol (2010) 2.04
Diagnostic and therapeutic approach of systemic amyloidosis. Neth J Med (2004) 1.43
Amyloidosis: prognosis and treatment. Semin Arthritis Rheum (1994) 1.01
Hereditary periodic fever and reactive amyloidosis. Clin Exp Med (2005) 0.99
Risk factors for severe Muckle-Wells syndrome. Arthritis Rheum (2010) 0.98
Amyloidosis: a clinical overview. Rheum Dis Clin North Am (2013) 0.95
The fresco of autoinflammatory diseases from the pediatric perspective. Autoimmun Rev (2011) 0.89
Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes. Int J Immunopathol Pharmacol (2012) 0.85
Clinical and biochemical landmarks in systemic autoinflammatory diseases. Ann Med (2011) 0.84
Nephrotic syndrome and AA amyloidosis revealing adult-onset cryopyrin-associated periodic syndrome. Ren Fail (2013) 0.79
Renal involvement in AA amyloidosis: clinical outcomes and survival. Kidney Blood Press Res (2013) 0.77
Analysis of clinical and pathological characteristics of 28 cases with renal amyloidosis. Clin Lab (2011) 0.75
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis (2010) 3.47
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Haematologica (2008) 2.29
Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. J Clin Oncol (2005) 2.12
Rare NLRP12 variants associated with the NLRP12-autoinflammatory disorder phenotype: an Italian case series. Clin Exp Rheumatol (2013) 2.09
Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children. Ann Rheum Dis (2013) 2.09
Mevalonate kinase genotype in children with recurrent fevers and high serum IgD level. Rheumatol Int (2012) 1.95
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study. J Clin Oncol (2007) 1.94
Intranasal lidocaine and midazolam for procedural sedation in children. Arch Dis Child (2010) 1.61
Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis (2012) 1.59
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Intern Emerg Med (2008) 1.54
Serum amyloid-A in Behçet's disease. Clin Rheumatol (2014) 1.47
The enigma of periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome. Pediatr Infect Dis J (2014) 1.39
Ultrasound-guided central venous catheterization in cancer patients improves the success rate of cannulation and reduces mechanical complications: a prospective observational study of 1,978 consecutive catheterizations. World J Surg Oncol (2010) 1.30
Primary pancreatic lymphoma. Report of five cases. Haematologica (2005) 1.28
Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics (2008) 1.20
Role of image-guided fine-needle aspiration biopsy in the management of patients with splenic metastasis. World J Surg Oncol (2007) 1.15
Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there? Rheumatol Int (2010) 1.14
Efficacy of anakinra in refractory Behçet's disease sacroiliitis. Clin Exp Rheumatol (2014) 1.12
The systemic-onset variant of juvenile idiopathic arthritis needs to be recorded as an autoinflammatory syndrome: comment on the review by Nigrovic. Arthritis Rheumatol (2014) 1.12
Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra. J Pediatr (2010) 1.07
Penile involvement in Henoch-Schönlein purpura with good prognosis. Scand J Urol Nephrol (2007) 1.05
The role of infection in Kawasaki syndrome. J Infect (2013) 1.03
Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas. Pediatr Rheumatol Online J (2011) 1.03
Debate around infection-dependent hemophagocytic syndrome in paediatrics. BMC Infect Dis (2013) 1.01
Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC). Am J Clin Oncol (2006) 1.01
Helicobacter pylori, gastrointestinal symptoms, and metabolic control in young type 1 diabetes mellitus patients. Pediatrics (2003) 1.00
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome. Int J Rheum Dis (2013) 0.98
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Clin Res Cardiol (2012) 0.95
International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients. Rheumatology (Oxford) (2014) 0.95
Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series. Dermatology (2014) 0.94
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediators Inflamm (2013) 0.93
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study. Am J Hematol (2014) 0.93
The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy. Clin Rheumatol (2014) 0.93
Anakinra treatment in drug-resistant Behcet's disease: a case series. Clin Rheumatol (2013) 0.92
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. Haematologica (2007) 0.92
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome. Clin Rheumatol (2014) 0.91
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol (2013) 0.91
Current therapeutic approaches to autoimmune chronic uveitis in children. Autoimmun Rev (2010) 0.90
Long-term clinical course of patients carrying the Q703K mutation in the NLRP3 gene: a case series. Clin Exp Rheumatol (2012) 0.90
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. Clin Exp Rheumatol (2012) 0.89
Short- and long-term effects of spa therapy in knee osteoarthritis. Am J Phys Med Rehabil (2010) 0.88
Successful treatment of tumor necrosis factor receptor-associated periodic syndrome with canakinumab. Ann Intern Med (2012) 0.88
Safety issues and concerns of new immunomodulators in rheumatology. Expert Opin Drug Saf (2014) 0.88
The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection. Clin Rheumatol (2014) 0.87
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol (2014) 0.87
Effects of spa therapy on serum leptin and adiponectin levels in patients with knee osteoarthritis. Rheumatol Int (2010) 0.87
Registries in rheumatological and musculoskeletal conditions. Paediatric Behçet's disease: an international cohort study of 110 patients. One-year follow-up data. Rheumatology (Oxford) (2010) 0.87
Misdiagnosis of Ewing's sarcoma of the ilium at the pelvis X-ray. Rheumatol Int (2011) 0.86
Can fibroblast growth factor (FGF)-23 circulating levels suggest coronary artery abnormalities in children with Kawasaki disease? Clin Exp Rheumatol (2013) 0.86
Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome. Ann Rheum Dis (2012) 0.86
Do children's upper respiratory tract infections benefit from probiotics? BMC Infect Dis (2014) 0.86
Recurrent pericarditis: autoimmune or autoinflammatory? Autoimmun Rev (2012) 0.86
From the Mediterranean to the sea of Japan: the transcontinental odyssey of autoinflammatory diseases. Biomed Res Int (2013) 0.85
Sudden shock from capillary leak. Lancet (2012) 0.85
Quality of water, dialysate and infusate. Contrib Nephrol (2007) 0.85
Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins. World J Nephrol (2012) 0.85
Diagnosis of PFAPA syndrome applied to a cohort of 17 adults with unexplained recurrent fevers. Clin Exp Rheumatol (2012) 0.85
Treatment strategies for childhood noninfectious chronic uveitis: an update. Expert Opin Investig Drugs (2011) 0.85
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature. Autoimmun Rev (2012) 0.84
Autoinflammatory diseases and cardiovascular manifestations. Ann Med (2011) 0.84
Lung parenchymal consolidation as an uncommon presentation and cause of delayed diagnosis in atypical Kawasaki syndrome. Rheumatol Int (2008) 0.84
Presentation of esophageal cancer with solitary splenic metastasis. Am J Clin Oncol (2005) 0.84
Clinical and biochemical landmarks in systemic autoinflammatory diseases. Ann Med (2011) 0.84
Determinants of bone mineral density, bone mineral content, and body composition in a cohort of healthy children: influence of sex, age, puberty, and physical activity. Rheumatol Int (2011) 0.83
Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature. Clin Rheumatol (2014) 0.83
Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent. Intensive Care Med (2002) 0.83
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). PLoS One (2013) 0.83
Weekly oral alendronate in mevalonate kinase deficiency. Orphanet J Rare Dis (2013) 0.83
Kawasaki syndrome and concurrent Coxsackie virus B3 infection. Rheumatol Int (2010) 0.83
Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based study. Clin Exp Rheumatol (2012) 0.83
Interleukin-1 Inhibition in Behçet's disease. Isr Med Assoc J (2016) 0.83
Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. Clin Rheumatol (2015) 0.82
Dyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatment? Cardiovasc Ther (2010) 0.82
Water treatment for hemodialysis: a 2005 update. Contrib Nephrol (2005) 0.82
Advanced waldenström's macroglobulinemia: a case of possible cure after systemic chemotherapy, splenic radiation and splenectomy. Acta Haematol (2002) 0.82
A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant. Leuk Lymphoma (2011) 0.82
Enteral nutrition in patients with acute renal failure. Kidney Int (2004) 0.81
Epidermolysis bullosa and the partnership with autoimmunity: what should we assimilate? Immunol Res (2015) 0.81
Antiangiogenic VEGF isoform in inflammatory myopathies. Mediators Inflamm (2013) 0.81
Anakinra treatment in patients with gout and type 2 diabetes. Clin Rheumatol (2014) 0.81
Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease. Medicine (Baltimore) (2015) 0.81
Prognostic impact of atypical presentation in pediatric systemic lupus erythematosus: results from a multicenter study. J Pediatr (2010) 0.80
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α. Eur J Immunol (2013) 0.80
Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis. Clin Rheumatol (2014) 0.80
Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes. J Pediatr Gastroenterol Nutr (2004) 0.80